To include your compound in the COVID-19 Resource Center, submit it here.

SAR 1118: Additional Phase II data

Additional data from a double-blind Phase II trial in 230 patients showed that twice-daily topical SAR

Read the full 167 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE